The American Journal of Surgery
Volume 187, Issue 1 , Pages 52-57 , January 2004

Obesity and lymphatic mapping with sentinel lymph node biopsy in breast cancer

  • Marybeth Hughes, M.D.

      Affiliations

    • Department of Surgery, Eastern Virginia Medical School, 825 Fairfax Ave., Suite 610, Norfolk, VA 23507, USA
  • ,
  • Thomas G Goffman, M.D.

      Affiliations

    • Department of Radiation Oncology, Eastern Virginia Medical School, Norfolk, VA, USA
  • ,
  • Roger R Perry, M.D.

      Affiliations

    • Department of Surgery, Eastern Virginia Medical School, 825 Fairfax Ave., Suite 610, Norfolk, VA 23507, USA
  • ,
  • Christine Laronga, M.D.

      Affiliations

    • Department of Surgery, Eastern Virginia Medical School, 825 Fairfax Ave., Suite 610, Norfolk, VA 23507, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-757-446-8965; fax: +1-757-446-8951.

Received 6 December 2002 ,Revised 9 April 2003

References 

  1. Baker R, Montague A, Childs J. A comparison of modified radical mastectomy to radical mastectomy in the treatment of operable breast cancer. Ann Surg. 1979;189:553–559
  2. Robinson GN, Van Heerden JA, Payne W, et al.  The primary surgical treatment of carcinoma of the breast (a changing trend toward modified radical mastectomy). Mayo Clin Proc. 1976;51:433–442
  3. Turner L, Swindell R, Bell W, et al.  al. Radical versus modified radical mastectomy for breast cancer Ann R Coll Surg Engl. 1981;63:239–243
  4. Maddox W, Carpenter J, Laws H, et al.  A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg. 1983;198:207–212
  5. Fisher B, Montague E, Redmond C, et al.  Comparison of radical mastectomy with alternative treatments for primary breast cancer (a first report of results from a prospective randomized clinical trial). Cancer. 1977;39:2827–2839
  6. Veronesi U, Saccozzi R, Del Vecchio M, et al.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981;305:6–11
  7. van Dongen JA, Bartelink H, et al.  A randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer. EORTC 108001 trial. J Natl Cancer Inst Monogr. 1992;11:15–18
  8. Fisher B, Bauer M, Margolese R, et al.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665–673
  9. Roses DF, Brooks AD, Harris MN, et al.  Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg. 1999;230:194–201
  10. Cox CE, Haddad F, Bass S, et al.  Lymphatic mapping in the treatment of breast cancer. Oncology. 1998;12:1283–1292
  11. Veronesi U, Paganelli G, Viale G, et al.  Sentinel lymph node biopsy and axillary dissection in breast cancer (results in a large series). J Natl Cancer Inst. 1999;91:368–373
  12. Cody HS. Sentinel lymph node mapping in breast cancer. Oncology. 1999;13:25–34
  13. Krag D, Weaver D, Ashikaga T, et al.  The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1998;339:941–946
  14. McMasters KM, Guiliano AE, Ross MI, et al.  Sentinel lymph node biopsy for breast cancer—not yet the standard-of-care. N Engl J Med. 1998;339:990–995
  15. Tafra L, Lannin D, Swanson M, et al.  Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg. 2001;233:51–59
  16. Giuliano AE, Haigh PI, Brennan MB, et al.  Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000;18:2553–2559
  17. Burak WE, Hollenbeck ST, Zervos EE, et al.  Sentinel lymph node results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg. 2002;183:23–27
  18. Breslin TM, Cohen L, Sahin A, et al.  Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000;18:3480–3486
  19. Nason KS, Anderson BO, Byrd DR, et al.  Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer. 2000;89:2187–2194
  20. Brady EW. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J. 2002;8:97–100
  21. Cox CE, Dupont E, Whitehead GF, et al.  Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J. 2002;8:88–91
  22. Ahrendt GM, Laud P, Tjoe J, et al.  Does breast tumor location influence success of sentinel lymph node biopsy?. J Am Coll Surg. 2002;194:278–284
  23. Haigh PI, Hansen NM, Qi K, et al.  Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol. 2000;7:21–27
  24. Feldman SM, Krag DN, McNally RK, et al.  Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg. 1999;188:248–254
  25. Wong SL, Edwards MJ, Chao C, et al.  The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol. 2002;9:272–277
  26. Wong SL, Chao C, Edwards MJ, et al.  Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am Surg. 2001;67:522–528
  27. Chao C, Wong SL, Woo C, et al.  Reliable lymphatic drainage to axillary sentinel lymph nodes regardless of tumor location within the breast. Am J Surg. 2001;182:307–311
  28. Kuerer HM, Sahin AA, Hunt KK, et al.  Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999;230:72–78
  29. Morrow M, Rademaker AW, Bethke KP, et al.  Learning sentinel node biopsy (results of a prospective randomized trial of two techniques). Surgery. 1999;126:714–720
  30. Lam PB, Vacek PM, Geller BM, et al.  The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont. Cancer. 2000;89:369–375
  31. Werner RS, McCormick B, Petrek J, et al.  Arm edema in conservatively managed breast cancer (obesity is a major predictive factor). Radiology. 1991;180:177–184
  32. Segerstrom K, Bjerle P, Graffman S, et al.  Factors that influence the incidence of brachial oedema after treatment for breast cancer. Scand J Plast Reconstr Surg Hand Surg. 1992;26:223–227

PII: S0002-9610(03)00439-2

doi: 10.1016/j.amjsurg.2003.04.004

The American Journal of Surgery
Volume 187, Issue 1 , Pages 52-57 , January 2004